It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Developed by researchers from more than a dozen research institutions and led by a team at the Scripps Research Institute in the US, the drug is effective against doses of HIV-1, HIV-2 and SIV (simian immunodeficiency virus) that have been extracted from humans or rhesus macaques - including what researchers consider to be the ‘hardest-to-stop’ variants. It worked against doses of HIV that are way higher than what would be transmitted between humans, and works for at least eight months after injection.
"Our compound is the broadest and most potent entry inhibitor described so far,” lead researcher Michael Farzan from the Scripps Institute said in a press release. "Unlike antibodies, which fail to neutralise a large fraction of HIV-1 strains, our protein has been effective against all strains tested, raising the possibility it could offer an effective HIV vaccine alternative.”
While traditional vaccines work by delivering a tiny, weakened dose of a virus to train your immune system to thwart an actual attack, this drug does something quite different. The way HIV infects a person is by targeting their T lymphocytes - a very specialised type of white blood cell - and injecting its own genetic material inside to transform them into HIV-producing machines. So, quite literally, it turns our immune systems against us.
But what Farzan’s team has discovered is that a particular type of protein found on the surface of white blood cells can actually bind to the surface of the HIV virus in two different places simultaneously, which means that not only does the virus no longer have a chance to change the position of its receptors to escape, it’s also being blocked from entering the T lymphocyte cells.
"When antibodies try to mimic the receptor, they touch a lot of other parts of the viral envelope that HIV can change with ease," said one of the team, Matthew Gardner, from the Scripps Institute. "We've developed a direct mimic of the receptors without providing many avenues that the virus can use to escape, so we catch every virus thus far.”
there is no cure . there are some people who have some sort of "chromosome deletion" to which i'll address later .
originally posted by: Vasa Croe
Interesting. and yeah, I have the same wonder....is this also a cure to those that already have it? If they have found immunity, a cure can't be that far off....but likely "put off" simply to make that extra buck saying it only works for a couple years then you have to get it again....
originally posted by: SecretKnowledge
a reply to: Kapusta
Can you put up a link please?
Thanks in advance
originally posted by: Vasa Croe
Interesting. and yeah, I have the same wonder....is this also a cure to those that already have it? If they have found immunity, a cure can't be that far off....but likely "put off" simply to make that extra buck saying it only works for a couple years then you have to get it again....